In CML CD34+ cells BCR-ABL expression leads to an increase of FOXO3a in the cytoplasm, where it is transcriptionally inactive, whereas in normal CD34+ cells, FOXO3a is predominantly detected in the nucleus. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.